See how research connects peptides to biological targets, signaling pathways, and biological processes.
This tool shows, for each peptide, which biological target the available research points to, how directly that relationship is supported, and how it connects to broader signaling pathways and biological processes. It describes what research suggests about biological mechanisms -- not proven health or treatment outcomes, and not medical advice. See each peptide's full research profile for complete detail, citations, and safety information.
Mechanism research for MitoCore's current product catalog.
Showing 37 of 37 peptides
Evidence legend
Relationship support
Directly supported
Supported indirectly
Inferred from related evidence
Uncertain
Evidence context
Human research
Preclinical research
Human + preclinical research
Review / established literature
Related compound/program context
Evidence context uncertain
Understanding mechanism evidence
This tool describes research into biological targets, signaling pathways, and biological processes -- not proven health or treatment outcomes, and not medical advice. Relationship-support and evidence-context labels describe the type and directness of research available, not proof of safety or effectiveness. See each peptide's full research profile for complete detail, citations, and safety information.
Mechanism profiles
Epitalon
1 mechanism relationship · Supported indirectly · Preclinical research
PathwayOther Defined PathwayTelomerase/telomere-length regulation via hTERT expression is a genome-maintenance mechanism. The current PF01-PF21 taxonomy does not contain a dedicated telomere-maintenance or genome-stability family, so this relationship is placed in PF14 rather than being forced into an ill-fitting existing family.
Relationship details
Epitalon → hTERT — Supported indirectlyExact Epitalon increased hTERT expression in human cell systems and increased telomerase activity in normal fibroblast/epithelial cells; this is a supported-indirect expression/activity relationship, not evidence of direct Epitalon-hTERT binding, and the response is cell-context dependent.
Evidence context
Preclinical research
Evidence is preclinical, cell-culture based. No direct physical Epitalon-hTERT or Epitalon-telomerase binding has been demonstrated. The governed relation reflects hTERT expression and telomerase-activity changes only, not receptor-style agonism or direct enzymatic activation. Findings are cell-context dependent: normal IBR.3 fibroblasts and HMEC epithelial cells showed hTERT upregulation with increased telomerase activity after prolonged treatment, while tested 21NT and BT474 breast-cancer cell lines showed hTERT upregulation without a significant telomerase-activity increase under tested conditions, with Alternative Lengthening of Telomeres (ALT) involvement instead. ALT is a separate, deferred mechanism and is not part of this record. The modern primary source (PMID 40908429) has a formal published correction (PMID 41240216) that replaced Figures 1, 2, and 3; the corrected article identifies a figure-rendering/black-background problem, but this governance record does not independently pixel-verify the pre- and post-correction figures, and numeric fold-change values from those figures are intentionally omitted pending independent human verification. Historical primary support (PMID 12937682) is from the original Khavinson research lineage and is not independent replication by itself; the modern primary source (PMID 40908429) is independent work by Al-Dulaimi, Thomas, Matta, and Roberts from a different research group. No direct hTERT-promoter, DNA, histone-H1/H1.3, or H19 target-engagement mechanism is established -- a discussion-section hypothesis about direct DNA/histone binding in the modern source is author speculation, explicitly unsupported by data. No human anti-aging, longevity, rejuvenation, lifespan-extension, or therapeutic efficacy is established. This relationship must not be generalized to 'Epitalon activates telomerase' in all cells. PMID 41240216 is a correction notice, not independent mechanistic evidence.
Sources
Central Citation Library reference: b05-epitalon-04-epitalon-increases-telomere-length-in-huma
Central Citation Library reference: b05-epitalon-03-epithalon-peptide-induces-telomerase-activ
Central Citation Library reference: b05-epitalon-04b-correction-telomere-length-pmid41240216
What is established
A target (hTERT) and pathway family (Other Defined Pathway) are documented.
What remains unclear
Specific downstream signaling steps and biological-process associations are not yet documented.
Evidence is preclinical, cell-culture based. No direct physical Epitalon-hTERT or Epitalon-telomerase binding has been demonstrated. The governed relation reflects hTERT expression and telomerase-activity changes only, not receptor-style agonism or direct enzymatic activation. Findings are cell-context dependent: normal IBR.3 fibroblasts and HMEC epithelial cells showed hTERT upregulation with increased telomerase activity after prolonged treatment, while tested 21NT and BT474 breast-cancer cell lines showed hTERT upregulation without a significant telomerase-activity increase under tested conditions, with Alternative Lengthening of Telomeres (ALT) involvement instead. ALT is a separate, deferred mechanism and is not part of this record. The modern primary source (PMID 40908429) has a formal published correction (PMID 41240216) that replaced Figures 1, 2, and 3; the corrected article identifies a figure-rendering/black-background problem, but this governance record does not independently pixel-verify the pre- and post-correction figures, and numeric fold-change values from those figures are intentionally omitted pending independent human verification. Historical primary support (PMID 12937682) is from the original Khavinson research lineage and is not independent replication by itself; the modern primary source (PMID 40908429) is independent work by Al-Dulaimi, Thomas, Matta, and Roberts from a different research group. No direct hTERT-promoter, DNA, histone-H1/H1.3, or H19 target-engagement mechanism is established -- a discussion-section hypothesis about direct DNA/histone binding in the modern source is author speculation, explicitly unsupported by data. No human anti-aging, longevity, rejuvenation, lifespan-extension, or therapeutic efficacy is established. This relationship must not be generalized to 'Epitalon activates telomerase' in all cells. PMID 41240216 is a correction notice, not independent mechanistic evidence.
Key terms
Looking for research areas instead?
Peptide Explorer shows what areas a peptide is researched in. This tool shows how the underlying biology appears to work.
Educational use only. Not medical advice. MitoCore Biosciences does not diagnose, treat, cure, prevent, prescribe, sell peptides, recommend dosing, or provide instructions for human use.
